Ben Bowen has been appointed vice president of business development at Biolog.
Bowen will be responsible for launching Biolog’s forthcoming mammalian cell Phenotype Microarray product. Previously, Bowen served as vice president of discovery research at Lynx Therapeutics. He has also worked at Pioneer Hi-Bred (now part of DuPont).
ForteBio this week named William Albright as the company’s chief financial officer.